跳至主要内容
临床试验/JPRN-UMIN000029588
JPRN-UMIN000029588已完成未知

Treatment of amyotrophic lateral sclerosis with high-dose methylcobalamin: phase III clinical trial - Japan Early-stage Trial of high-dose methylcobalamin for ALS (JETALS)

Tokushima University0 个研究点目标入组 128 人开始时间: 2017年10月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • *Tracheostomy. *Experienced non-invasive positive pressure ventilation. *%FVC >= 60%. *Chronic obstructive pulmonary disease. *Edaravone use within 4weeks before starting the observation period. *Initiated newly introduced riluzole therapy after starting the observation period. Or received dose escalation or resumed administration of riluzole therapy after previous down titration or discontinuation. *Cognitive impairment. *Participated in another clinical study within 12 weeks before starting the observation period.

研究者

相似试验

招募中
2 期
arrow band ultraviolet B (UVB) phototherapy in amyotrophic lateral sclerosisAmyotrophic Lateral SclerosisNeurological - Neurodegenerative diseasesInflammatory and Immune System - Other inflammatory or immune system disorders
ACTRN12615000802505Western Sydney Local Health District20
尚未招募
4 期
Multiple Sclerosis treatment with Autologous Hematopoietic Stem Cell Transplantation (MS-ACT): A long-term prospective observational study in the NetherlandsMultiple sclerosis1000381610012303MS
NL-OMON53285Vrije Universiteit Medisch Centrum24
进行中(未招募)
1 期
Study evaluating the treatment with colchicine for the amyotrophic lateral sclerosisDefinite or probable amyotrophic lateral sclerosisMedDRA version: 20.0Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: LLTClassification code 10052889Term: ALSSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2017-004459-21-ITAZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA54
已完成
2 期
Perampanel for sporadic amyotrophic lateral sclerosis (ALS): A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 TrialSporadic amyotrophic lateral sclerosis
JPRN-UMIN000025614Department of Neurology, Tokyo Medical University66
招募中
不适用
A Registered Cohort Study on Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis
NCT04008329First Affiliated Hospital of Fujian Medical University2,000